AUPH Aurinia Pharmaceuticals Inc - marketcomposite.com

AUPH - Aurinia Pharmaceuticals Inc5:05:57 PM 4/18/2024

Price

$4.85

-0.06 (-1.22%)

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.

Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Topics

30d

Biotechnology-1.60%

Peers

30d

PIRS-4.20%

REGN0.80%

leak data

Stock news

AUPH

UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference04-16-2024 14:48:00 PM

ROCKVILLE, Md. & EDMONTON, Alberta, April 16, 2024--UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference

AUPH

Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 202404-15-2024 10:00:00 AM

ROCKVILLE, Md. & EDMONTON, Alberta, April 15, 2024--Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024

AUPH

Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference04-09-2024 10:00:00 AM

ROCKVILLE, Md. & EDMONTON, Alberta, April 09, 2024--Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference

AUPH

When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?04-07-2024 14:47:52 PM

With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals...

AUPH

11 Oversold Biotech Stocks To Buy Right Now03-17-2024 21:20:04 PM

In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]

AUPH

We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn03-08-2024 18:52:29 PM

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

AUPH

Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program02-29-2024 13:30:00 PM

ROCKVILLE, Md. & EDMONTON, Alberta, February 29, 2024--Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program

AUPH

Aurinia to Participate in Upcoming Investor Healthcare Conferences02-27-2024 13:30:00 PM

ROCKVILLE, Md. & EDMONTON, Alberta, February 27, 2024--Aurinia to Participate in Upcoming Investor Healthcare Conferences

AUPH

Aurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations02-17-2024 12:35:24 PM

Aurinia Pharmaceuticals ( NASDAQ:AUPH ) Full Year 2023 Results Key Financial Results Revenue: US$175.5m (up 31% from FY...

AUPH

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript02-16-2024 14:22:38 PM

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript February 15, 2024 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.18. AUPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to Aurinia […]